Company intelligence / Profile preview

UBS Group AG

Zurich, Zurich, Switzerland

Ownership: Public · UBS
Employees: ~70000
Development stage: Other

Overview

UBS is a leading global financial services company, primarily operating as an investment bank, wealth manager, and asset manager. While not directly involved in drug development, it plays a significant role in financing biotech and healthcare innovation through various investment funds, such as the UBS Oncology Impact Fund, supporting third-party companies from preclinical to commercial stages.

Industry: Investors

Partnerships

Strategic partnerships in asset managementImpact investing partnerships

Financials

Market cap: $180.5B
Total revenue: $19.6B
Enterprise value: $188.2B

Beyond the preview

Go deeper on UBS Group AG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBS Group AG.

Explore the full profile